SAMUEL SHOPTAW: Open Payments
NPI 1245949239 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 51 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $451 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $152 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Eisai Inc. | 5 | $95 |
| CSL Behring | 3 | $64 |
| Medtronic, Inc. | 2 | $57 |
| SpringWorks Therapeutics, Inc. | 2 | $50 |
| Neurelis, Inc. | 2 | $47 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
Products named: FYCOMPA, Rystiggo, HYQVIA, Leqembi, Hizentra, DUET, GOMEKLI, VALTOCO.
Industry payments across KY — which companies pay providers there.
